OBJECTIVES: To report clinical data on maternal outcome, mode of delivery and immediate neonatal outcome in women infected with COVID-19. METHODS: Retrospective data collection. RESULTS: A total of 8.6% of the total population of hospitalised SARS-CoV-2 positive pregnant women were admitted to a critical care unit. The premature birth rate for births before 34+0 weeks of gestation among pregnant women who tested positive for SARS-CoV-2 was 7.1%. One newborn (3.6%) tested positive for SARS-CoV-2 two days after birth and showed symptoms. CONCLUSIONS: Pregnant women with COVID-19 seem to be at higher risk of invasive ventilation, admission to a critical care unit and preterm birth, and should therefore be considered a high-risk-population.
OBJECTIVES: To report clinical data on maternal outcome, mode of delivery and immediate neonatal outcome in womeninfected with COVID-19. METHODS: Retrospective data collection. RESULTS: A total of 8.6% of the total population of hospitalised SARS-CoV-2 positive pregnant women were admitted to a critical care unit. The premature birth rate for births before 34+0 weeks of gestation among pregnant women who tested positive for SARS-CoV-2 was 7.1%. One newborn (3.6%) tested positive for SARS-CoV-2 two days after birth and showed symptoms. CONCLUSIONS: Pregnant women with COVID-19 seem to be at higher risk of invasive ventilation, admission to a critical care unit and preterm birth, and should therefore be considered a high-risk-population.
Authors: Elena Vazquez-Alejo; Laura Tarancon-Diez; Itzíar Carrasco; Sara Vigil-Vázquez; Mar Muñoz-Chapuli; Elena Rincón-López; Jesús Saavedra-Lozano; Mar Santos-Sebastián; David Aguilera-Alonso; Alicia Hernanz-Lobo; Begoña Santiago-García; Juan Antonio de León-Luis; Patricia Muñoz; Manuel Sánchez-Luna; María Luisa Navarro; Mª Ángeles Muñoz-Fernández Journal: Front Immunol Date: 2022-07-14 Impact factor: 8.786